insitro

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. MacroGenics Gets $40m Up Front For St

Listen to the podcast below: Open Media Medtronic Report Finds Latest Tech Absent From Most ORs A recent report from device maker Medtronic plc offers good news and bad news for surgeons and patie

At the recent HLTH Europe 2024 conference, held from 17-20 June in Amsterdam, health tech leaders discussed areas where generative AI and AI are already having a significant impact in health care and

Cash is flooding into biopharmaceuticals, but regenerative medicine companies in particular have raked in large sums of cash – in part, because of the high upfront investment in manufacturing, but als